Keyphrases
Basic Fibroblast Growth Factor (bFGF)
100%
Granulocyte Colony-stimulating Factor (G-CSF)
85%
Filgrastim
51%
Cushing's Syndrome
51%
Leukemia
47%
Human Bone Marrow
46%
Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF)
46%
Leukemic Cells
45%
Phase I Trial
39%
Anemia
39%
Tumor Necrosis Factor-α
39%
Interleukin-1β
37%
Cell Growth
35%
CSF-1
34%
Tumor
34%
Testicle
33%
Epoetin Alfa
30%
Feminizing
30%
Estrogen
30%
Human Mesenchymal Stem Cells (hMSCs)
29%
Bone Marrow Culture
29%
Recombinant Human Tumor Necrosis Factor
29%
Arsenic Trioxide
27%
Flavopiridol
27%
Gynecomastia
27%
Growth Factors
27%
Granulocyte Macrophages
27%
Erythroid
26%
Bone Marrow
26%
Interferon-α (IFN-α)
25%
Chronic Lymphocytic Leukemia
23%
Myelopoiesis
22%
HL-60 Cells
21%
Chemotherapy
21%
Complete Remission
21%
Progenitor Cells
20%
Acute Promyelocytic Leukemia
20%
Leukemia Cell Lines
20%
High Dose
20%
Heparan Sulfate Proteoglycans
20%
Phase II Trial
20%
Quality of Life
19%
Acute Myeloid Leukemia
19%
B-cell Leukemia
19%
Cortisol
19%
Testosterone
18%
Glycosylphosphatidylinositol-specific Phospholipase D
18%
Myeloid Progenitors
18%
Tumorous
18%
Transforming Growth Factor-β
18%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
46%
Recombinant Granulocyte Colony Stimulating Factor
46%
Filgrastim
42%
Fibroblast Growth Factor 2
41%
Phase I Trials
39%
Anemia
37%
Interleukin 1
37%
Neutropenia
35%
Tumor Necrosis Factor
33%
Disease
33%
Recombinant Erythropoietin
32%
Chemotherapy
32%
Growth Factor
31%
Granulocyte Macrophage Colony Stimulating Factor
30%
Chronic Lymphatic Leukemia
30%
Flavopiridol
27%
Promyelocytic Leukemia
27%
Neoplasm
25%
Interferon
24%
Granulocyte Colony Stimulating Factor
24%
Antitumor Activity
21%
Diethylstilbestrol
20%
Acute Myeloid Leukemia
19%
Colony Stimulating Factor
19%
Clinical Study
19%
Remission
18%
Gynecomastia
18%
Advanced Cancer
18%
Hyperandrogenism
18%
B Cell Leukemia
18%
Ketoconazole
18%
Arsenite
18%
Recombinant Interleukin 2
18%
Breast Cancer
18%
Arsenous Acid
18%
Cytokine
18%
Clinical Trial
18%
Hydrocortisone
17%
Receptor
14%
Cytarabine
14%
Glucocorticoid
14%
Syndrome
13%
Lymphocytosis
13%
Infection
12%
Adverse Event
12%
Hematologic Malignancy
12%
Leukemia
12%
Diarrhea
11%
Cytotoxicity
11%
Androgen
11%
Medicine and Dentistry
Cushing Syndrome
52%
Fibroblast Growth Factor 2
46%
Neoplasm
42%
Tumor Necrosis Factor
31%
Granulocyte
30%
Recombinant Granulocyte Colony Stimulating Factor
27%
Granulocyte Colony Stimulating Factor
23%
Hydrocortisone
23%
Bone Marrow Stromal Cell
23%
Myelopoiesis
22%
Disease
22%
Cell Line
21%
Testes
20%
Acute Promyelocytic Leukemia
20%
In Vitro
18%
Congenital Adrenal Hyperplasia
18%
Bartter Syndrome
18%
Arsenic Trioxide
18%
Melarsoprol
18%
Gynecomastia
18%
Cancer Growth Factor
18%
Hydroxyprogesterone
17%
Carcinoma
17%
Cytokine
16%
Programmed Cell Death
15%
Diethylstilbestrol
15%
Cell Growth
14%
Adrenal Insufficiency
14%
Neutrophil
14%
Cortodoxone
14%
Hyperaldosteronism
13%
Interferon
13%
Osteoporosis
13%
Corticotropin
13%
Granulocyte Macrophage Colony Stimulating Factor
13%
Clinical Study
13%
Colony Stimulating Factor
12%
Glucocorticoid
12%
Aldosterone
11%
Leukemia Cell Line
11%
B-Cell Chronic Lymphocytic Leukemia
11%
Adrenal Gland
11%
Precursor
11%
Hepatoma Cell
11%
Myeloid Leukemia Cell Line
11%
Anemia
10%
Transitional Cell Carcinoma
10%
Urothelium
10%
Tumor Cell
10%
Interstitial Cell
10%